Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 3, 2008, Pages 308-315

  Giegling, Ina ^a   Moreno De Luca, Daniel ^b   Rujescu, Dan ^a   Schneider, Barbara ^c   Hartmann, Annette M ^a   Schnabel, Axel ^c   Maurer, Konrad ^c   Möller, Hans Jürgen ^a   Serretti, Alessandro ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Dopa decarboxylase; Dopamine synthesis; Genetics; Suicide; Tyrosine hydroxylase

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; AGGRESSION; ANGER; ARTICLE; BEHAVIOR; BORDERLINE STATE; DOPAMINERGIC SYSTEM; FEMALE; GENETIC VARIABILITY; GERMANY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; VIOLENCE;

ADOLESCENT; ADULT; AGED; DOPA DECARBOXYLASE; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; SUICIDE, ATTEMPTED; TYROSINE 3-MONOOXYGENASE;

EID: 42149172589     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30599     Document Type: Article

References (57)

1. Asberg M. 1997. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann NY Acad Sci 836:158-181.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Baud P. 2005. Personality traits as intermediary phenotypes in suicidal behavior: Genetic issues. Am J Med Genet Part C 133C:34-42.
4. Bergquist J, Traskman-Bendz L, Lindstrom MB, Ekman R. 2002. Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. Eur Neuropsychopharmacol 12:153-158.
5. Biegon A, Fieldust S. 1992. Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse 10:79-82.
6. Birt C, Bille-Brahe U, Cabecadas M, Chishti P, Corcoran P, Elgie R, van Heeringen K, Horte L-G, Marchi AG, Ostamo A, Petridou E, Renberg ES, Stone DH, Wiik J, Williamson E. 2003. Suicide mortality in the European Union. Eur J Public Health 13:108-114.
7. Boadle-Biber MC. 1993. Regulation of serotonin synthesis. Prog Biophys Mol Biol 60:1-15.
8. Brent DA, Mann JJ. 2005. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet Part C 133C:13-24.
9. Bronisch T, Brunner J, Bondy B, Rujescu D, Bishof G, Heuser I, Muller-Oerlinghausen B, Hawellek B, Maier W, Rao ML, Felber W, Lewitzka U, Oehler J, Broocks A, Hohagen F, Lauterbach E. 2005. A multicenter study about Neurobiology of Suicidal Behavior: Design, development, and preliminary results. Arch Suicide Res 9:19-26.
10. Buss AH, Durkee A. 1957. An inventory for assessing different kinds of hostility. J Consult Psychol 21:343-349.
11. Cavalli Sforza L. 1994. The History and Geography of Human Genes. Princeton, New Jersey, USA: Princeton University Press.
12. Chen TJ, Blum K, Mathews D, Fisher L, Schnautz N, Braverman ER, Schoolfield J, Downs BW, Comings DE. 2005. Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders. Med Hypotheses 65:703-707.
13. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates. pp 8-14.
14. Curtis D, Sham PC. 2006. Estimated haplotype counts from case-control samples cannot be treated as observed counts. Am J Hum Genet 78:729-730.
15. Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, Roy M, Mann JJ, Benkelfat C, Turecki G. 2005a. Risk factors for suicide completion in major depression: A case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry 162: 2116-2124.
16. Dumais A, Lesage AD, Lalovic A, Seguin M, Tousignant M, Chawky N, Turecki G. 2005b. Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry 162:1375-1378.
17. Engstrom G, Alling C, Blennow K, Regnell G, Traskman-Bendz L. 1999. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 9:399-405.
18. First MB, Spitzer RL, Gibbon M, Williams BW, Benjamin L. 1990. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). New York: Biometrics Research Department, New York State Psychiatric Institute.
19. First MB, Spitzer RL, Gibbon M, Williams JB. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
20. Golomb BA, Tenkanen L, Alikoski T, Niskanen T, Manninen V, Huttunen M, Mednick SA. 2002. Insulin sensitivity markers: Predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol 55:767-773.
21. Gunnell D, Lewis G. 2005. Studying suicide from the life course perspective: Implications for prevention. Br J Psychiatry 187:206-208.
22. Hampel R, Selg H. 1975. FAF-Fragebogen zur Erfassung von Aggressivitätsfaktoren Hogrefe Verlag für Psychologie. Handanweisung, Gottingen
23. Kendler KS. 2005. "A gene for...": The nature of gene action in psychiatric disorders. Am J Psychiatry 162:1243-1252.
24. Korner J, Rietschel M, Hunt N, Castle D, Gill M, Nothen MM, Craddock N, Daniels J, Owen M, Fimmers R., et al. 1994. Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German-British sample of manic depressive patients and controls. Psychiatr Genet 4:167-175.
25. Kulessa C, Möller H, Schaller S, Schmidtke A, Torhorst A, Wächtler C, Wechsung P, Wedler H. 1987. Basisdokumentation suizidalen Verhaltens Hogrefe. Göttingen.
26. Mann JJ. 2003. Neurobiology of suicidal behaviour. Nat Rev Neurosci 4:819-828.
27. McGuffin P, Marusic A, Farmer A. 2001a. What can psychiatric genetics offer suicidology? Crisis 22:61-65.
28. McKenzie N, Landau S, Kapur N, Meehan J, Robinson J, Bickley H, Parsons R, Appleby L. 2005. Clustering of suicides among people with mental illness. Br J Psychiatry 187:476-480.
29. Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J. 1998. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7:423-428.
30. Meyer-Lindenberg A, Weinberger D. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7(10): 818-827.
31. Moskvina V, Holmans P, Schmidt KM, Craddock N. 2005. Design of case-controls studies with unscreened controls. Ann Hum Genet 69:566-576.
32. O'Malley KL, Anhalt MJ, Martin BM, Kelsoe JR, Winfield SL, Ginns EI. 1987. Isolation and characterization of the human tyrosine hydroxylase gene: Identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26:6910-6914.
33. Oquendo MA, Mann JJ. 2000. The biology of impulsivity and suicidality. Psychiatr Clin North Am 23:11-25.
34. Ordway GA, Smith KS, Haycock JW. 1994. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 62:680-685.
35. Persson ML, Wasserman D, Geijer T, Jonsson EG, Terenius L. 1997. Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Res 72:73-80.
36. Pierce DW. 1981. The predictive validation of a suicide intent scale: A five year follow-up. Br J Psychiatry 139:391-396.
37. Pitchot W, Hansenne M, Ansseau M. 2001a. Role of dopamine in non-depressed patients with a history of suicide attempts. Eur Psychiatry 16:424-427.
38. Pitchot W, Reggers J, Pinto E, Hansenne M, Fuchs S, Pirard S, Ansseau M. 2001b. Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology 26:331-335.
39. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. 1991. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 19:3753.
40. Pritchard JK, Rosenberg NA. 1999. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228.
41. Purcell S, Sham P. 2001. Genetic Power Calculator. London: Social, Genetic & Developmental Research Centre.
42. Purcell S, Cherny SS, Sham P. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
43. Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J. 2003. Dopamine D3 receptor gene polymorphism and violent behavior: Relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 110:561-572.
44. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, Hesselbrock VM, Nurnberger JI Jr, Schuckit MA, Begleiter H. 1995. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19:1018-1023.
45. Roy A, Karoum F, Pollack S. 1992. Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide. Arch Gen Psychiatry 49:447-450.
46. Rujescu D, Giegling I, Sato T, Moeller HJ. 2001. A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatr Genet 11:169-172.
47. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ. 2003. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry 54:34-39.
48. Rujescu D, Thalmeier A, Moeller H-J, Bronisch T, Giegling I, 2007. Molecular genetic findings in suicidal behavior; What is beyond the serotonergic system? Arch Suicide Res 11:17-40.
49. Ryding E, Ahnlide JA, Lindstrom M, Rosen I, Traskman-Bendz L. 2006. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 148:195-203.
50. Serretti A, Mandelli L, Giegling I, Schneider B, Hartmann AM, Schnabel A, Maurer K, Moller HJ, Rujescu D. 2007. HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet 144(3):291-299.
51. Souery D, Oswald P, Linkowski P, Mendlewicz J. 2003. Molecular genetics in the analysis of suicide. Ann Med 35:191-196.
52. Spielberger C. 1991. State-Trait Anger Expression Inventory Assessment Resources. Odessoa, FL: Psychological Assessment Resources.
53. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, Slutske WS, Dunne MP, Martin NG. 1998. Suicidal behaviour: An epidemiological and genetic study. Psychol Med 28:839-855.
54. Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T. 1992. Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31:2229-2238.
55. Turecki G. 2005. Dissecting the suicide phenotype: The role of impulsive-aggressive behaviours. J Psychiatry Neurosci 30:398-408.
56. Van Heeringen C, Marusic A. 2003. Understanding the suicidal brain. Br J Psychiatry 183:282-284.
57. Westling S, Ahren B, Traskman-Bendz L, Westrin A. 2004. High CSF-insulin in violent suicide attempters. Psychiatry Res 129:249-255.